10th Global Pharma Quality Summit: Paving the Future of Excellence in India

The Indian Pharmaceutical Alliance hosts the 10th Global Pharmaceutical Quality Summit on February 27-28, 2025, in Mumbai, with the theme of 'Navigating the Next Decade for Global Excellence.' Industry leaders, regulators, and experts unite to explore strategies addressing quality culture, AI-driven manufacturing, and supply chain resilience.

The Indian Pharmaceutical Alliance is set to host the 10th Global Pharmaceutical Quality Summit (GPQS) on February 27-28, 2025, in Mumbai. The event, under the theme 'Navigating the Next Decade for Global Excellence,' aims to join forces with industry leaders, regulators, and experts eager to shape the future of pharmaceutical quality and manufacturing.

A key highlight includes the inaugural session with Nilesh Gupta, Chair of IPA's Quality Forum and Managing Director of Lupin, followed by a keynote from Arvind Virmani, Member of NITI Aayog, and insights from Rajeev Raghuvanshi, Drug Controller General of India. A panel with CEOs from Cipla, Lupin, Sun Pharma, and Zydus Lifesciences will discuss India's path to global leadership.

Not only will the summit feature 50+ speakers over 11 sessions, but it will also spotlight innovations in manufacturing processes, sustainability, talent development, and more. Attendees can expect the launch of McKinsey's report on the future of India's pharmaceutical operations and two IPA Best Practices Reports. This gathering solidifies India's commitment to pharma quality as it sets its sights on a globally leading position.

(With inputs from agencies.)